tiprankstipranks
Processa Pharmaceuticals jumps 28% after Phase 2 study update
PremiumThe FlyProcessa Pharmaceuticals jumps 28% after Phase 2 study update
5M ago
Processa:  First patient dosed in Phase 2 clinical trial of NGC-Cap for MBC
Premium
The Fly
Processa: First patient dosed in Phase 2 clinical trial of NGC-Cap for MBC
5M ago
Processa Pharmaceuticals reports Q2 EPS ($1.01) vs. ($1.94) last year
Premium
The Fly
Processa Pharmaceuticals reports Q2 EPS ($1.01) vs. ($1.94) last year
6M ago
Processa Pharmaceuticals Welcomes New CFO Russell Skibsted
PremiumCompany AnnouncementsProcessa Pharmaceuticals Welcomes New CFO Russell Skibsted
7M ago
Processa Pharmaceuticals appoints Skibsted as CFO
Premium
The Fly
Processa Pharmaceuticals appoints Skibsted as CFO
7M ago
Processa announces results from preliminary eval of Phase 1b trial with NGC-Cap
Premium
The Fly
Processa announces results from preliminary eval of Phase 1b trial with NGC-Cap
9M ago
Processa presents two abstracts at AACR 2024 including data on NGC-Cap trial
PremiumThe FlyProcessa presents two abstracts at AACR 2024 including data on NGC-Cap trial
11M ago
Processa Pharmaceuticals’ Future in Jeopardy: A Dive into Its Financial Crisis and Industry Risks
Premium
Company Announcements
Processa Pharmaceuticals’ Future in Jeopardy: A Dive into Its Financial Crisis and Industry Risks
11M ago
PCSA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PCSA Earnings this Week: How Will it Perform?
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100